• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Lyra Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 391K and EPS of USD -15.3982
04:00
Lyra Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 25K (forecast USD 154.25K), actual EPS USD -3.3849 (forecast USD -5.255)
04:00
Oct14
Hanbury Brown's Rating and Target Price for Lyra Therapeutics
11:22
Oct6
Hanbury Brown Rates Healthcare Sector Stocks
19:46
Aug13
Lyra Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 183K (forecast USD 181.25K), actual EPS USD -5.5144 (forecast USD -5.5266)
03:00
Lyra Therapeutics released FY2025 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 366 K and EPS of USD -12.0001
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 25 K, Net Income -5.984 M, EPS -3.3849

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 183 K, Net Income -7.437 M, EPS -5.5144

May28
Reverse Stock Split(EST)

1-for-50 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
11.550
+111.54%
+6.110
BUUU
15.270
+79.86%
+6.780
AEHL
1.970
+74.34%
+0.840
DAIC
0.6724
+70.01%
+0.267
AFJK
70.080
+60.55%
+26.430
PFSA
0.1094
+60.18%
+0.041
ULY
2.570
+41.99%
+0.730
ONTF
8.020
+36.86%
+2.160
MENS
3.701
+33.11%
+0.920
SCWO
2.274
+29.57%
+0.519
View More